Revolo Biotherapeutics Announces Clinical Trial Authorization to Initiate Phase 2 Trial of ‘1104 in Allergic Disease in the UK

NEXT STORY
ALK og Grandpharma indgår partnerskab om markedsføring af den første adrenalinpen i Kina
PREV STORY
Exagen Appoints Ana Hooker to Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche launches new high throughput configurations for cobas pro integrated solutions to increase testing efficiency

author_avatar
NASDAQ Market News

ACR 2019: Lilly Presents 52-Week Head-to-Head (SPIRIT-H2H) Data from TALTZ® (ixekizumab) Versus Humira® (adalimumab) Trial in Psoriatic Arthritis

author_avatar
NASDAQ Market News

Radius Health to Announce Third Quarter 2017 Financial Results, Host Conference Call and Live Webcast on November 2, 2017

WALTHAM, Mass., Oct. 09, 2017 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that ...

author_avatar
NASDAQ Market News